US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monkeypox Concept

1,449.91

+26.251.84%

Number of Gainers:5

Number of Losers:6

Number of Flat:- -

PE:- -

High:1,453.52

Open:1,423.65

Low:1,416.12

Close:1,423.66

Loading ...

Gilead Shares Down 3.6% After Quarterly Revenue Miss

THOMSON REUTERS

Viatris to Present at the BofA Securities 2025 Healthcare Conference

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gilead Shares Down 4.2% Premarket After Quarterly Revenue Miss

THOMSON REUTERS

Gilead : RBC Raises Target Price to $92 From $89

THOMSON REUTERS

Gilead Sciences (GILD) Gets a Buy from Oppenheimer

Gilead Q1 Biktarvy Sales $3.15 Bln

THOMSON REUTERS

Gilead Outlook 2025 EPS $5.65 - $6.05 VS Prior Guidance $5.95 - $6.35

THOMSON REUTERS

Gilead Q1 Total REV $6.67 Bln VS Ibes Estimate $6.81 Bln

THOMSON REUTERS

Gilead Q1 Veklury Sales $302 Mln

THOMSON REUTERS

Gilead Outlook 2025 Adj EPS, Product Sales Remains Unchanged

THOMSON REUTERS

Gilead Q1 Product Sales USD 6,613 Million

THOMSON REUTERS

Gilead Sciences Announces First Quarter 2025 Financial Results

THOMSON REUTERS

Gilead Sciences Announces First Quarter 2025 Financial Results

BRIEF-Tonix Pharmaceuticals Presented Data On Potential Mpox Vaccine TNX-801 At World Vaccine Congress Washington 2025

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group

GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1449.9094,"timestamp":1746043199999,"preClose":1423.6627,"halted":0,"volume":26432676,"delay":0,"changeRate":0.018436,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":26.246704,"latestTime":"04-30 16:00:00 EDT","open":1423.6481,"high":1453.5166,"low":1416.1212,"amount":1425942628.692589,"amplitude":0.026267,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.525976,"peRate":27.664127,"turnoverRate":0.009744,"increases":5,"decrements":6,"flats":0,"marketCap":163672603351,"floatMarketCap":163037168426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1453.5166,"amplitude":0.026267,"preClose":1423.6627,"low":1416.1212,"pbRate":"3.525976","latestPrice":1449.9094,"volume":26432676,"delay":0,"open":1423.6481,"prevYearClose":1284.7982,"prevWeekClose":1405.5511,"prevMonthClose":1449.9094,"prevQuarterClose":1502.9401,"fiveDayClose":1437.0104,"twentyDayClose":1493.5931,"sixtyDayClose":1346.2891,"secType":"PLATE","market":"US","turnoverRate":0.009744,"peRate":27.664127,"marketCap":163672603351,"floatMarketCap":163037168426,"timestamp":1746043199999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":5,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530136072","title":"Gilead Shares Down 3.6% After Quarterly Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2530136072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530136072?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:32","pubTimestamp":1745587936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4N3R31CJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU2087621335.USD","BK4566","BK4568","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","GILD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2530933185","title":"Viatris to Present at the BofA Securities 2025 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2530933185","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530933185?lang=en_us&edition=fundamental","pubTime":"2025-04-25 18:59","pubTimestamp":1745578740,"startTime":"0","endTime":"0","summary":"PITTSBURGH, April 25, 2025 /PRNewswire/ -- Viatris Inc. , a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV, on Tuesday, May 13, 2025. The company's presentation will begin at 5 p.m. PT / 8 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viatris-present-bofa-securities-2025-105900711.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viatris-present-bofa-securities-2025-105900711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4137","BK4588","LU1839511570.USD","VTRS","LU2087621335.USD","HCSG","BK4007","BK4583"],"gpt_icon":0},{"id":"2530183726","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2530183726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530183726?lang=en_us&edition=fundamental","pubTime":"2025-04-25 18:52","pubTimestamp":1745578338,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD – Research Report), Merit Medi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-684?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-684?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD","LU0289739699.SGD","BK4532","BK4583","LU1571399168.USD","BK4139","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1066053197.SGD","LU2087621335.USD","BK4137","LU1430594728.SGD","LU2089984988.USD","BK4585","BK4588","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","LU0058720904.USD","BK4568","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","BK4566","BK4550","LU0889565916.HKD","HCSG","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2530903420","title":"Gilead Shares Down 4.2% Premarket After Quarterly Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530903420?lang=en_us&edition=fundamental","pubTime":"2025-04-25 17:13","pubTimestamp":1745572426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4N3R30Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU1430594728.SGD","BK4578","BK4588","LU0234570918.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0320765992.SGD","LU2089984988.USD","LU0889565916.HKD","IE0002270589.USD","LU1571399168.USD","IE00B19Z3B42.SGD","BK4139","LU1585245621.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU0058720904.USD","LU1839511570.USD","BK4532","LU2087621335.USD","BK4550","LU0289739699.SGD","BK4566","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4585","GILD","BK4583"],"gpt_icon":0},{"id":"2530527926","title":"Gilead : RBC Raises Target Price to $92 From $89","url":"https://stock-news.laohu8.com/highlight/detail?id=2530527926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530527926?lang=en_us&edition=fundamental","pubTime":"2025-04-25 13:37","pubTimestamp":1745559472,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R301W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4585","LU0889565916.HKD","LU1839511570.USD","LU0320765992.SGD","GILD","LU0109394709.USD","BK4568","IE00B3T34201.USD","LU1430594728.SGD","LU1571399168.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4532","IE00BKVL7J92.USD","LU1066053197.SGD","LU2468319806.SGD","BK4578","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4550","LU2087621335.USD","LU2089984988.USD","BK4588","BK4139","LU1066051498.USD","LU1585245621.USD","BK4566"],"gpt_icon":0},{"id":"2530458942","title":"Gilead Sciences (GILD) Gets a Buy from Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530458942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530458942?lang=en_us&edition=fundamental","pubTime":"2025-04-25 11:55","pubTimestamp":1745553315,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Matthew Biegler from Oppenheimer maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-gets-a-buy-from-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","BK4566","LU0289739699.SGD","OPY","IE00BSNM7G36.USD","BK4583","GILD","IE00B19Z3581.USD","BK4578","LU0320765992.SGD","BK4568","LU1585245621.USD","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4550","LU1430594728.SGD","LU2468319806.SGD","BK4139","LU1839511570.USD","LU0109394709.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4532","LU1066051498.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4588","LU1571399168.USD","IE0002270589.USD","BK4127","LU0889565916.HKD","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2530960859","title":"Gilead Q1 Biktarvy Sales $3.15 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530960859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530960859?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1430594728.SGD","LU1585245621.USD","LU0889565916.HKD","LU0058720904.USD","BK4588","LU2087621335.USD","BK4532","BK4568","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","GILD","LU2089984988.USD","LU1571399168.USD","BK4585","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU1839511570.USD","IE00BKVL7J92.USD","BK4578","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU0320765992.SGD","BK4139","BK4583","LU1066051498.USD"],"gpt_icon":0},{"id":"2530608969","title":"Gilead Outlook 2025 EPS $5.65 - $6.05 VS Prior Guidance $5.95 - $6.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2530608969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530608969?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU1571399168.USD","LU2087621335.USD","BK4585","LU1585245621.USD","BK4578","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","GILD","BK4532","LU2089984988.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","IE00B7SZLL34.SGD","BK4583","LU1430594728.SGD","LU1066051498.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4550","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2530396086","title":"Gilead Q1 Total REV $6.67 Bln VS Ibes Estimate $6.81 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530396086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530396086?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4550","BK4532","IE00B19Z3B42.SGD","LU2089984988.USD","IE00BKVL7J92.USD","BK4585","LU1066051498.USD","LU1571399168.USD","IE00B3T34201.USD","LU0058720904.USD","IE00B19Z3581.USD","GILD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1430594728.SGD","IE0002270589.USD","LU0234570918.USD","BK4588","IE00BZ1G4Q59.USD","LU0889565916.HKD","BK4566","LU1585245621.USD","LU1839511570.USD","BK4578","BK4139","BK4568","LU0289739699.SGD","LU1066053197.SGD","LU2087621335.USD","BK4583"],"gpt_icon":0},{"id":"2530196700","title":"Gilead Q1 Veklury Sales $302 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196700?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2530071967","title":"Gilead Outlook 2025 Adj EPS, Product Sales Remains Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2530071967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530071967?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524922,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nP8N3JT0JZ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0234570918.USD","BK4583","BK4139","IE0002270589.USD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","BK4532","LU1066051498.USD","LU0058720904.USD","BK4585","LU0889565916.HKD","BK4550","LU1839511570.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1571399168.USD","GILD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2089984988.USD","BK4568","LU2087621335.USD","IE00B7SZLL34.SGD","BK4578"],"gpt_icon":0},{"id":"2530880960","title":"Gilead Q1 Product Sales USD 6,613 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2530880960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530880960?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nPLX7136FF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IE00B19Z3B42.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU0234570918.USD","GILD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4583","BK4550","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","BK4532","LU0109394709.USD","LU1571399168.USD","LU2087621335.USD","BK4566","LU1585245621.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","IE0002270589.USD","BK4578","LU0320765992.SGD"],"gpt_icon":0},{"id":"2530496707","title":"Gilead Sciences Announces First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530496707?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA5YJYJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","BK4139","IE0002270589.USD","LU0320765992.SGD","LU1585245621.USD","BK4568","LU0234570918.USD","LU0058720904.USD","LU2468319806.SGD","BK4550","LU0109394709.USD","BK4583","LU1839511570.USD","LU2087621335.USD","LU2089984988.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","BK4585","LU1066053197.SGD","LU0889565916.HKD","BK4566","IE00BSNM7G36.USD","BK4578","IE00B19Z3581.USD","IE00BKVL7J92.USD","BK4588","BK4532","LU1430594728.SGD","LU1066051498.USD","GILD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2530186996","title":"Gilead Sciences Announces First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2530186996","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530186996?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524920,"startTime":"0","endTime":"0","summary":"Product Sales Excluding Veklury Increased 4% Year-Over-Year to $6.3 billion. Biktarvy Sales Increased 7% Year-Over-Year to $3.1 billion. FOSTER CITY, Calif., April 24, 2025----Gilead Sciences, Inc.  announced today its first quarter 2025 results of operations.\"Gilead had a strong start to the year driven by excellent commercial and clinical execution along with disciplined expense management,\" said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. \"Our base business grew 4% year-over-year, primarily led by Biktarvy’s continued strength, and we announced positive topline Phase 3 results for Trodelvy plus pembrolizumab in first line PD-L1+ metastatic triple negative breast cancer. With the upcoming June PDUFA date for lenacapavir for HIV prevention, and continued progress across our diverse pipeline, we look forward to building on our positive momentum throughout the year.\". As of March 31, 2025, Gilead had $7.9 billion of cash and cash equivalents compared to $10.0 billion as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-announces-first-quarter-200200808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2529931981","title":"BRIEF-Tonix Pharmaceuticals Presented Data On Potential Mpox Vaccine TNX-801 At World Vaccine Congress Washington 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931981","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529931981?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:27","pubTimestamp":1745497621,"startTime":"0","endTime":"0","summary":"BRIEF-Tonix Pharmaceuticals Presented Data On Potential Mpox Vaccine TNX-801 At World Vaccine Congress Washington 2025April 24 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:TONIX PHARMACEUTICA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA3GBLWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0},{"id":"2529617659","title":"Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2529617659","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529617659?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:37","pubTimestamp":1745426220,"startTime":"0","endTime":"0","summary":"This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while Regeneron REGN was in the spotlight on updates on key drugs.Bristol Myers announced disappointing top-line results from the phase III ARISE study on schizophrenia drug Cobenfy . The study is evaluating the efficacy and safety of Cobenfy as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia.Treatment with Cobenfy as an adjunctive demonstrated a 2.0-point reduction in the Positive and Negative Syndrome Scale total score compared to placebo with an atypical antipsychotic at week six. However, this data did not reach the threshold for statistical significance for the primary endpoint. Shares of BMY were down following the data announcement.Preliminary analyses suggest that Cobenfy as an adjunctive treatment to an atypical antipsychotic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-bmy-down-163700964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","LU0306806265.USD","SNY","LU0289739699.SGD","BK4097","BK4583","BMY","LU1868837300.USD","GILD","IE0002141913.USD","BK4578","LU0053666078.USD","LU0320765992.SGD","LU0234570918.USD","LU1291159041.SGD","LU2089984988.USD","LU2362541273.HKD","OS","LU0225771236.USD","LU0058720904.USD","REGN","LU1430594728.SGD","LU1839511570.USD","LU0306807586.USD","LU1670710588.SGD","PFS","IE00B3T34201.USD","LU0868494617.USD","BK4007","BK4559","BK4532","LU1093756168.USD","LU1670711123.USD","LU2237438978.USD","LU1989771016.USD","IE00B19Z3B42.SGD","CRL","LU1670711040.USD","LU1093756325.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2133065610.SGD","LU2362541513.USD","LU1670710661.SGD","LU1868836914.USD","LU2023250504.SGD","BK4585","IE00BKVL7J92.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2529538076","title":"Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538076","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529538076?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:22","pubTimestamp":1745425344,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Cheap Stocks to Buy Under $10. In this article, we are going to take a look at where Viatris Inc.  stands against other cheap stocks to buy under $10.We first used the Finviz stock screener to compile a list of cheap stocks that had a forward P/E ratio under 15 and were trading under $10. We then selected the 10 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q4 2024. The hedge fund data was sourced from Insider Monkey’s database which tracks the moves of over 1000 elite money managers.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viatris-inc-nasdaq-vtrs-best-162224482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","BK4583","USJW.SI","USAW.SI","BK4112","IE00B64PRP62.GBP","NQmain","LU2095319765.USD","BK4601",".IXIC","TQQQ","LU1839511570.USD","IE00BKPKM429.USD","QLD","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2087621335.USD","NVIW.SI","BK4585","IE00BGHQF748.EUR","SQQQ","LU2210150020.SGD","QID","MNQmain","BK4007","BK4588","NDAQ","PSQ","VTRS","BK4594"],"gpt_icon":1},{"id":"2529365786","title":"The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2529365786","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529365786?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:25","pubTimestamp":1745414700,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Gilead Sciences GILD, Bristol Myers BMY, Merck MRK, AbbVie ABBV and Sanofi SNY.Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi are all slated to release their quarterly results later this week.Gilead has an impeccable earnings track record so far. It beat earnings estimates in each of the last four quarters, delivering an average surprise of 19.47%. In the last reported quarter, GILD beat earnings estimates by 13.77%.Gilead's flagship HIV therapies — Biktarvy and Descovy — are likely to have boosted the company's top line. However, the company's revenues are likely to have been impacted by the new Medicare Part D model, which increases manufacturer discount obligations during the initial coverage and catastrophi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-132500143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN8TJ469.HKD","ABBV","LU0211331839.USD","LU1917777945.USD","LU2361044949.HKD","BK4532","BK4583","LU1670711040.USD","LU2089283258.USD","LU0238689110.USD","LU1162221912.USD","LU1023059063.AUD","LU0820561909.HKD","LU1074936037.SGD","LU1989772840.SGD","LU0265550946.USD","LU2237443465.HKD","LU1670711123.USD","IE00B1BXHZ80.USD","MRK","LU2237443549.SGD","BK4581","LU0109394709.USD","SNYNF","LU1670710661.SGD","LU2023250504.SGD","BK4534","LU2125154778.USD","LU0225771236.USD","LU0306807586.USD","IE00B7SZLL34.SGD","MYE","BMY","BK4126","LU0738911758.USD","IE0009355771.USD","GILD","LU1116320901.HKD","SNY","SG9999002224.SGD","LU0234570918.USD","LU0256863902.USD","LU1244550494.USD","SG9999014542.SGD","LU0545039389.USD","IE0002141913.USD","IE00BVYPNW00.USD","LU0985320562.USD","LU2023251221.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2529868377","title":"Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2529868377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529868377?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:08","pubTimestamp":1745413680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 23, 2025 09:08 ET (13:08 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4567","LU1854103824.USD","BK4585","LU1854104046.USD","BK4588","DGX","BK4583"],"gpt_icon":0},{"id":"2529625636","title":"GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529625636","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529625636?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:00","pubTimestamp":1745413200,"startTime":"0","endTime":"0","summary":"ATLANTA, GA - April 23, 2025  - GeoVax Labs, Inc. , a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it will report first quarter 2025 financial results on Thursday, May 1, 2025, after the close of U.S. markets. Following the release, management will host a live conference call and webcast, including Q&A, at 4:30 p.m. ET to provide a corporate update and discuss financial results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-report-first-quarter-2025-130000003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4022","BK4232","BK4568","BK4585","GOVXW","R","BK4535","BK4139","BK4548","BK4588","BK4551","BNTX","BK4583","GOVX"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":73,"code":"91000000","status":"200"}]}}